If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.

Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Embellence Group EMBELL Apr 25, 2025 34.90 -1.41   
 Embracer Group B EMBRACB Apr 25, 2025 117.82 +1.32   
 Emilshus EMILPREF Apr 25, 2025 29.36 +0.53   
 Emilshus B EMILB Apr 25, 2025 43.25 -3.89   
 Enad Global 7 EG7 Apr 25, 2025 11.84 -1.99   
 Enea ENEA Apr 25, 2025 65.40 +1.71   
 Enersize ENERS Apr 25, 2025 0.00 0.00   
 Engcon AB ENGCONB Apr 25, 2025 97.90 +3.05   
 Eniro Group ENRO Apr 25, 2025 0.41 +1.25   
 Enorama Pharma ERMA Apr 25, 2025 3.09 0.00   
 Enrad ENRAD Apr 25, 2025 10.90 +12.14   
 Envar ENVAR Apr 25, 2025 17.90 -1.38   
 Envipco Holding ENVIPO Apr 25, 2025 58.00 0.00   
 Envirologic B ENVIB Apr 25, 2025 24.90 +4.62   
 Enzymatica ENZY Apr 25, 2025 3.50 +3.55   
 Eolus Vind B EOLUB Apr 25, 2025 50.20 +0.90   
 Ependion AB EPEN Apr 25, 2025 138.00 +5.67   
 Epiroc A EPIA Apr 25, 2025 206.00 +1.43   
 Epiroc B EPIB Apr 25, 2025 182.70 +1.50   
 Episurf Medical B EPISB Apr 25, 2025 0.12 -0.66   
 EQL Pharma EQL Apr 25, 2025 79.00 +0.16   
 EQT EQT Apr 25, 2025 272.50 +1.38   
 Ericsson A ERICA Apr 25, 2025 80.20 +1.26   
 Ericsson B ERICB Apr 25, 2025 79.88 +0.81   
 ES Energy Save Holding ESGRB Apr 25, 2025 20.00 -5.66   
 Essity A ESSITYA Apr 25, 2025 271.50 0.00   
 Essity B ESSITYB Apr 25, 2025 270.40 -0.11   
 Eurobattery Minerals BAT Apr 25, 2025 0.06 +11.54   
 Everysport Group AB EVERY Apr 25, 2025 19.20 +0.52   
 Evolear AB EVOL Apr 25, 2025 1.65 -2.94   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.